Depreciation

Organigram Reports Record First Quarter Fiscal 2023 Results

Retrieved on: 
Thursday, January 12, 2023
Alternative Medicine, Retail, Health, Other Retail, Other Health, Specialty, News, International Accounting Standards Board, EBITDA, COVID-19, Holy Mountain, International, Adjustment, Calendar, Webcast, Fiscal, Research, Depreciation, Investment, International Financial Reporting Standards, Security (finance), Bookkeeping, Organizational chart

Organigram currently expects Fiscal 2023 revenue to be higher than that of Fiscal 2022.

Key Points: 
  • Organigram currently expects Fiscal 2023 revenue to be higher than that of Fiscal 2022.
  • The Company believes it is better equipped to fulfill demand in Fiscal 2023 with larger harvests expected compared to Fiscal 2022.
  • The Company expects Q2 of Fiscal 2023 revenue to be higher than Q2 of Fiscal 2022.
  • The Company has a $29 million capex budget for Fiscal 2023 and if completed as planned during Fiscal 2023, the Company expects to generate positive free cash flows ("FCF") by the end of calendar 2023.

Babylon Delivers Strong 2022 Results, Beating Expectations

Retrieved on: 
Thursday, January 12, 2023
General Health, Health Insurance, Health, Other Health, GAAP, Sale, Conference, Depreciation, EBITDA, IPA, Adjustment, International, NYSE, Life insurance, Insurance

Babylon also expects to beat its previous IFRS Adjusted EBITDA guidance of $(270) million or less for 2022.

Key Points: 
  • Babylon also expects to beat its previous IFRS Adjusted EBITDA guidance of $(270) million or less for 2022.
  • In July 2022, Babylon announced cost reductions expected to deliver up to $100 million in yearly savings.
  • As a result of additional cost saving measures, Babylon expects to deliver an additional 25% in cost reductions on an annualized basis.
  • Accordingly, Babylon will report its full Q4 and 2022 year-end results and provide future guidance under U.S. GAAP.

NOTICE: Investors in Avaya Holdings Corp. with Substantial Losses Have Opportunity to Lead Class Action Lawsuit – AVYA

Retrieved on: 
Thursday, January 12, 2023
Class Action Lawsuit, Professional Services, Legal, News, Ethics, Avaya, Robbins Geller Rudman & Dowd LLP, Tax, Communication, Audit committee, Committee, COSO, NYSE, AVYA, Annual report, Software, CASE, Committee of Sponsoring Organizations of the Treadway Commission, Depreciation, Tobacco, Risk management

Lead plaintiff motions for the Avaya class action lawsuit must be filed with the court no later than March 6, 2023.

Key Points: 
  • Lead plaintiff motions for the Avaya class action lawsuit must be filed with the court no later than March 6, 2023.
  • A lead plaintiff acts on behalf of all other class members in directing the Avaya class action lawsuit.
  • The lead plaintiff can select a law firm of its choice to litigate the Avaya class action lawsuit.
  • An investor’s ability to share in any potential future recovery is not dependent upon serving as lead plaintiff of the Avaya class action lawsuit.

Brookdale Announces Leadership Changes and Provides Preliminary Views on the Full Year 2022 Financial Expectations

Retrieved on: 
Friday, January 13, 2023
Disease, Climate change, Security (finance), RevPAR, Public expenditure, COVID-19 testing, HIPAA, EBITDA, Failure, Privacy, Insurance, Medicaid, COVID-19, Unemployment, Cindy, GAAP, Housing, Income tax, Safety, Risk, Senior, NYSE, Adjustment, Vaccine, Medicare, Finance company collapses, 2006–2012 (New Zealand), Growth, Annual report, Contagious disease, Business communications operations management, Sale, Depreciation, BKD, Acquisition, Nature, Risk management, Management, Video game, Bank

NASHVILLE, Tenn., Jan. 13, 2023 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") today announced leadership changes designed to maximize efficiencies.

Key Points: 
  • NASHVILLE, Tenn., Jan. 13, 2023 /PRNewswire/ -- Brookdale Senior Living Inc. (NYSE: BKD) ("Brookdale" or the "Company") today announced leadership changes designed to maximize efficiencies.
  • The Company also announced select changes to its full-year 2022 financial expectations based on its preliminary, unaudited results.
  • Steven E. Swain, who serves as Brookdale's Executive Vice President and Chief Financial Officer, will terminate employment effective February 24, 2023.
  • Organizational restructuring costs include those related to the Company's efforts to reduce general and administrative expense and its senior leadership changes, including severance.

U.S. Middle Market Growth Shows a Positive Surprise

Retrieved on: 
Thursday, January 12, 2023
EBITDA, Tax, Confidentiality, Pressure, Public utility, Golub Capital, Health care, Growth, Index, Consumer, Depreciation, GDP, Bank, Finance

NEW YORK, Jan. 12, 2023 /PRNewswire/ -- Middle market private companies in the Golub Capital Altman Index experienced year-over-year earnings growth of 9% and revenue growth of 11% during the first two months of the fourth quarter of 2022.

Key Points: 
  • The Golub Capital Altman Index can provide early insight into financial performance of public companies and GDP in advance of earnings season.
  • NEW YORK, Jan. 12, 2023 /PRNewswire/ -- Middle market private companies in the Golub Capital Altman Index experienced year-over-year earnings growth of 9% and revenue growth of 11% during the first two months of the fourth quarter of 2022.
  • Lawrence E. Golub, CEO of Golub Capital, said, "This quarter's results are a positive surprise.
  • It measures the median revenue and earnings growth of approximately 110–150 private U.S. companies in the loan portfolio of Golub Capital, a leading middle market lender.

EQS-News: PIERER Mobility AG: Another record year in 2022

Retrieved on: 
Thursday, February 2, 2023
World championship, MV Agusta, EBITDA, R, RTÉ Executive Board, GP, Chakan, Red Bull KTM Factory Racing, Annual, Partnership, Annual general meeting, Grand Prix motorcycle racing, Agusta, Growth, Engineering, MOST, Workforce, Research, EBIT, Supervisory board, KTM, FIM, Motorcycle, Depreciation, EUR, Bajaj, Drug, DACH, Husqvarna

The PIERER Mobility Group increased its consolidated sales by 19.4 % to a new record of EUR 2,437 million (previous year: EUR 2,042 million) in the 2022 financial year despite severe supply chain challenges.

Key Points: 
  • The PIERER Mobility Group increased its consolidated sales by 19.4 % to a new record of EUR 2,437 million (previous year: EUR 2,042 million) in the 2022 financial year despite severe supply chain challenges.
  • As of December 31, 2022, the PIERER Mobility Group had a total of 6,088 employees, thereof about 5,000 in Austria.
  • Furthermore, through this cooperation, MV Agusta will partly distribute its product range through the worldwide distribution network of PIERER Mobility.
  • With another 17 world championship titles in 2022, PIERER Mobility AG looks back on an outstanding year in motorsports.

EQS-News: KPS AG: KPS exceeds revenue forecast for 2021/2022 and is optimistic about the new financial year 2022/2023

Retrieved on: 
Thursday, February 2, 2023
Aggression, EBITDA, Consultant, Tax, ERP, Annual, WKN, Growth, Federal Executive Boards, Workforce, EBIT, Supervisory board, Depreciation, KPS, Security (finance), Risk management

KPS increased revenue by 13.6% to 179.5 million euros and exceeded its original forecast of achieving mid to high single-digit revenue growth.

Key Points: 
  • KPS increased revenue by 13.6% to 179.5 million euros and exceeded its original forecast of achieving mid to high single-digit revenue growth.
  • Unterfoehring/Munich, 26 January 2023 – KPS AG (WKN: A1A6V4 / ISIN: DE000A1A6V48), Europe's leading management consultancy for digital transformation and process optimisation in retail, publishes the results for the 2021/2022 financial year.
  • In the financial year 2021/2022, KPS generated revenues of 179.5 million euros (previous year: 158.0 million euros) thus growing by 13.6%.
  • For example, revenues in Switzerland increased by 44.2% to 19.6 million euros and in Great Britain by 18.8% to 22.9 million euros.

EQS-News: Vantage Towers AG: Sustained organic revenue growth and continued progression in new macro site build

Retrieved on: 
Thursday, February 2, 2023
EBITDA, Vodafone, Maintenance, Growth, Cash conversion cycle, EV/Ebitda, Depreciation, Investment, Commercial property, Bookkeeping, Bank, Vantage

Recharged capital expenditure revenue represents direct recharges to Vodafone of capital expenditure in connection with upgrades to existing sites.

Key Points: 
  • Recharged capital expenditure revenue represents direct recharges to Vodafone of capital expenditure in connection with upgrades to existing sites.
  • Adjusted EBITDAaL margin is adjusted EBITDAaL divided by Group Revenue excluding recharged capital expenditure revenue.
  • Management uses adjusted EBITDAaL margin as a key measure of Vantage Towers’ profitability and as a means to track the efficiency of the business.
  • The European tower infrastructure business in Germany, Spain, Greece, Portugal, Romania, Czech Republic, Hungary, and Ireland in which Vantage Towers has a controlling interest.

EQS-News: BRAIN Biotech AG reports record figures in fiscal year 2021/22 − despite challenging geopolitical environment

Retrieved on: 
Thursday, February 2, 2023
Genome, EBITDA, R, Tax, BRAIN, Bioindustry Park Silvano Fumero, M-Brain Group, Environment, BioScience, Genomics, Growth, Federal Executive Boards, Research, Enzyme, Depreciation, EUR, Acquisition, Investment, Animal, Fine chemical

Zwingenberg, January 16, 2023 – BRAIN Biotech, a leading provider of solutions for the biologization of industry, today presented its Annual Report 2021/22.

Key Points: 
  • Zwingenberg, January 16, 2023 – BRAIN Biotech, a leading provider of solutions for the biologization of industry, today presented its Annual Report 2021/22.
  • Adriaan Moelker, CEO of BRAIN Biotech AG: "The 2021/22 financial year was characterized by various geopolitical crises and the continuing effects of the pandemic situation.
  • I am very proud to be able to present a record year in this challenging environment and would like to expressly thank all our employees for their outstanding personal commitment."
  • Biotechnological research and the development of biotechnological processes and products build the basis of the business activities of the BRAIN Biotech Group.

EQS-News: Infineon Technologies AG: INFINEON CONCLUDES A VERY PROFITABLE FIRST QUARTER AND RAISES ITS OUTLOOK FOR THE 2023 FISCAL YEAR SLIGHTLY, ADJUSTING FOR CURRENCY EFFECTS

Retrieved on: 
Thursday, February 2, 2023
Depreciation, CET, Internet, EST, Kulim District, IPC, Financial Oversight and Management Board for Puerto Rico v. Aurelius Investment, LLC, PSS, Connected, Webcast, ATV, Research, Surveillance Towed Array Sensor System, Investment, Acquisition, CSS, Video game, Security (finance), Oil, Cypress, Infineon Technologies

The adjusted gross margin also improved, from 46.3 percent in the fourth quarter of the 2022 fiscal year to 49.2 percent in the current quarter.

Key Points: 
  • The adjusted gross margin also improved, from 46.3 percent in the fourth quarter of the 2022 fiscal year to 49.2 percent in the current quarter.
  • The Segment Result increased in the first quarter of the 2023 fiscal year to €1,107 million, from €1,058 million in the prior quarter.
  • The Segment Result Margin improved from 25.5 percent in the fourth quarter of the 2022 fiscal year to 28.0 percent in the current quarter.
  • The tax expense in the first quarter of the 2023 fiscal year increased to €216 million, compared with €166 million in the prior quarter.